91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

The Investment Catalyst: A showcase of chemistry-led innovation for the angel investment community

14 May 2019 17:00-21:00, London, United Kingdom


Introduction
The 91AV and UK Business Angels Association (UKBAA) have once again partnered to connect the UK’s leading chemistry-focused start-ups and scale-ups with angel and early stage investors! Now in its third year, the Investment Catalyst has presented 32 leading innovators using chemistry to revolutionise life sciences, energy supply, construction, the automotive industry and more. To date, the Investment Catalysts’ cohort of businesses have raised a total of £3m in funding from attending investors, and we’re thrilled to have seen an incredible exit from one of our finalists at a phenomenal £630k!
 
The next Investment Catalyst event will be held in London on 14 May 2019, ​​bringing together the 91AV's vast network of science entrepreneurs and UKBAA's community of leading investors. After a competitive application series, 8 companies will be selected to present their pitch for investment to over 50 angels and leaders in the investment community.

In addition to hearing from these ground-breaking founders, we will also be joined by Andy Chapman as guest speaker. Andy has a PhD in 91AV from the University of Bristol and has a mixed background in academic and industrial positions. He left his position as Senior Lecturer at Kingston University London and joined Ziylo in 2017 as CSO. In the same year, he was appointed to the board of directors. In 2018, Ziylo was acquired by Novo Nordisk to use Ziylo’s Glucose Binding Molecule technology to develop for therapeutic application. Andy and the other board members founded Carbometrics after the acquisition, of which he is now CEO, to commercialise the same technology for diagnostic applications.

The event is open to investors, angel syndicates and groups and VC funds.  If you do not fit into one of these categories we reserve the right to cancel your registration. Registration for the event is free

The partnership

91AV-led innovation represents a broad and compelling opportunity for early-stage investors as it is integral to supporting an array of sectors and focuses. Businesses using chemistry at the centre of their technology offer possibilities that can drastically impact and improve the lives and work of citizens and communities everywhere, and together we are delighted to create a platform to showcase innovators first-hand to potential investors.
 
The 91AV currently supports over 300 small businesses across the UK by providing networking opportunities, grants and funding support, and help with recruitment and business promotion through their EnterprisePlus scheme.
 
UK Business Angels Association is the national trade association for angel and early-stage investment, working with 160-member organisations and 18,000 investors across the UK, enabling cutting edge start-ups and scale ups the opportunity and tools to connect with experienced investors to support their growth.

Caring Responsibilities

The RSC is keen to encourage and enable as many people as possible to attend our events, to benefit from the networking opportunities and the chance to hear talks from leaders in the field. If you have childcare, caring responsibilities or other care needs, and would like to attend this event, please do get in touch with us to see if there’s anything we can do to help enable you to attend.
 
Speakers
Carbon Cycle, United Kingdom

Carbon Cycle has created a commercially viable process for cleaning up phosphate by-product gypsum and calcium based mine tailings. Their new process unlocks the valuable rare earths/rare elements trapped within these wastes while cleaning up a multibillion ton waste problem.


Fresh Check UK, United Kingdom

Fresh Check is a colour-change spray that warns users about contamination on surfaces. If the spray changes from purple to any other colour, then the user must re-clean the surface. Fresh Check has sold to several companies with positive feedback.


Green Lizard Technologies, United Kingdom

Green Lizard Technologies is a unique, award winning start-up company which specialises in accelerating the commercialisation and deployment of novel technologies within the chemical and energy industries. One such technology is the conversion of waste glycerol to high value glycidol.


Kalium Diagnostics, United Kingdom

Kalium Diagnostics is working to transform the health of people suffering from electrolyte imbalances. Their blood potassium test kit for home and professional use is set to improve the safety and lifestyle of millions of people with kidney and cardiovascular conditions.


London Forest Products: Advanced 3D Carbon, United Kingdom

London Forest Products uses waste material from the paper and other forestry industries to 3D print pure carbon.


Low Sulphur Fuels, United Kingdom

LSF has developed a radical, disruptive and patented process to convert used oils, tyres and plastics to produce valuable low sulphur fuel and Naphtha while removing multiple toxic contaminants.


SGMA, United Kingdom

SGMA is a chemical company that has developed a new and unique platform introducing materials to the sol-gel process at a molecular level. Their sol-gel enables them to create chemical coatings which have unique properties that give other materials new characteristics.


VisusNano, United Kingdom

VisusNano is developing a drug-eluting intraocular lens for use in patients undergoing cataract surgery, the most common procedure worldwide. By improving patient outcomes, their technology has the potential to revolutionise cataract surgery in both the human and veterinary markets.


Andy Chapman, United Kingdom

Andy has a PhD in 91AV from the University of Bristol and has a mixed background in academic and industrial positions. He left his position as Senior Lecturer at Kingston University London and joined Ziylo in 2017 as CSO. In the same year, he was appointed to the board of directors. In 2018, Ziylo was acquired by Novo Nordisk to use Ziylo’s Glucose Binding Molecule technology to develop for therapeutic application. Andy and the other board members founded Carbometrics after the acquisition, of which he is now CEO, to commercialise the same technology for diagnostic applications.



Venue
The 91AV

The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by

Gallery
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*